This information is updated frequently and will continue to evolve. We will keep you posted of significant developments as they occur. If you have any questions on these materials, please contact Joel Kopperud at joel.kopperud@ciab.com.

The Council’s Positions

The Council’s largest priority in this fight is the preservation of Employer-Sponsored Insurance. Employer-Sponsored Insurance (ESI) is the most common type of health coverage in the United States, with more than 181 million Americans depending on it. But some in Congress want to tax employees on the cost of their health care benefits.

Imposing a tax on employer-sponsored health plans is a dangerous policy experiment that could significantly erode employer-sponsored health coverage. Any cap on the tax exclusion is a direct tax on employees and the middle class.

Click here to see our full page on ESI.

Get the Latest

See more by reading the latest Healthcare in Transition newsletter, below.

Questions?

Please contact Joel Wood at joel.wood@ciab.com or Joel Kopperud at joel.kopperud@ciab.com with any questions.

Healthcare in Transition Spotlight

Raising Our Voice to Lower Healthcare Costs
Healthcare In Transition | Aug. 14, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Payment reform, Surprise Medical Billing

August 15, 2019 The Council joined over 60 other employer groups on a letter to all Members of Congress urging them to pass the Lower Health Care Costs Act, which

Member Q&A: What Prescription Drug Importation could mean for Brokers
Healthcare In Transition | Aug. 14, 2019 | Employer Sponsored Insurance, Healthcare, Healthcare costs, Pharmacy supply chain, Prescription Drug Pricing, Pricing transparency

August 15, 2019 On the eve of the 2018 midterm elections, President Trump unveiled a new part of his “American Patients First” ideology, spurred by the difference in prices Americans

Social Determinants of Health Surface in U.S. Policy Agenda
Healthcare In Transition | Aug. 14, 2019 | Access to Care, Healthcare, Healthcare costs, Payment reform, Social Determinants of Health

August 15, 2019 Social Determinants of Health (SDOH) is a new industry buzzword, but it’s also a concept that’s existed for decades. Now it’s making its way into policy agenda

The White House to Drop another Price-Related Executive Order?
Healthcare In Transition | Jul. 17, 2019 | Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, Prescription Drug Pricing, Pricing transparency

July 18, 2019 President Trump announced the administration’s intention to release an executive order based on a “favored nations” clause. This approach suggests the U.S. would pay for pharmaceuticals at

Executive Order on Healthcare Pricing Transparency
Healthcare In Transition | Jul. 17, 2019 | Association health plans, Government Affairs, Healthcare, Healthcare reform, Pricing transparency, Short term health plan

June 18, 2019 The White House recently released an executive order aimed at requiring insurers, physicians and hospitals to provide patients with more digestible information about the cost of their

Senate HELP Committee Updates Bill Text on Lower Health Care Costs Act
Healthcare In Transition | Jul. 17, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, PBM, Prescription Drug Pricing, Surprise Medical Billing

July 18, 2019 The Council recently expressed strong support for the Lower Health Care Costs Act, which confronts some of the biggest obstacles to bringing costs down in the healthcare

Surprise Billing and Industry Transparency
Healthcare In Transition | Jul. 17, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, PBM, Prescription Drug Pricing, Surprise Medical Billing

July 18, 2019 The House Energy and Commerce Committee’s Subcommittee on Health recently marked up and voted in favor of drug transparency and surprise billing legislation. No Surprises Act (H.R.

The Administration Tosses Drug Rebating Rule
Healthcare In Transition | Jul. 17, 2019 | Government Affairs, Healthcare costs, Payment reform, PBM, Prescription Drug Pricing

July 18, 2019 The Trump administration announced it will not pursue its proposal to eliminate prescription drug rebates from government-facilitated health plans. While once touted as a critical step in

The End of the Cadillac Tax?
Healthcare In Transition | Jul. 17, 2019 | Cadillac Tax, Employer Sponsored Insurance, Government Affairs, Healthcare, Healthcare costs, Payment reform

July 18, 2019 The Council has long supported efforts to repeal the Cadillac Tax, and now lawmakers are primed to do just that. The House passed a bill to repeal

Resources

Raising Our Voice to Lower Healthcare Costs

August 15, 2019 The Council joined over 60 other employer groups on a letter to all Members of Congress urging them to pass the Lower Health Care Costs Act, which

Member Q&A: What Prescription Drug Importation could mean for Brokers

August 15, 2019 On the eve of the 2018 midterm elections, President Trump unveiled a new part of his “American Patients First” ideology, spurred by the difference in prices Americans

Social Determinants of Health Surface in U.S. Policy Agenda

August 15, 2019 Social Determinants of Health (SDOH) is a new industry buzzword, but it’s also a concept that’s existed for decades. Now it’s making its way into policy agenda

What Does It Mean To Be a “One-Stop Shop” in Benefits Enrollment? Q&A with Raj Singh, CEO, Flock

July 18, 2019 Flock is a benefits administration, compliance and HR platform created with the goal of engaging employees and streamlining the benefits administration process. We sat down with Raj

The White House to Drop another Price-Related Executive Order?

July 18, 2019 President Trump announced the administration’s intention to release an executive order based on a “favored nations” clause. This approach suggests the U.S. would pay for pharmaceuticals at

Executive Order on Healthcare Pricing Transparency

June 18, 2019 The White House recently released an executive order aimed at requiring insurers, physicians and hospitals to provide patients with more digestible information about the cost of their

Senate HELP Committee Updates Bill Text on Lower Health Care Costs Act

July 18, 2019 The Council recently expressed strong support for the Lower Health Care Costs Act, which confronts some of the biggest obstacles to bringing costs down in the healthcare

Surprise Billing and Industry Transparency

July 18, 2019 The House Energy and Commerce Committee’s Subcommittee on Health recently marked up and voted in favor of drug transparency and surprise billing legislation. No Surprises Act (H.R.

The Administration Tosses Drug Rebating Rule

July 18, 2019 The Trump administration announced it will not pursue its proposal to eliminate prescription drug rebates from government-facilitated health plans. While once touted as a critical step in

The End of the Cadillac Tax?

July 18, 2019 The Council has long supported efforts to repeal the Cadillac Tax, and now lawmakers are primed to do just that. The House passed a bill to repeal